← Back to All Filings

Exelon Director William P. Bowers Acquires Deferred Phantom Stock

Low SignificanceOctober 1, 2026 at 5:09:25 PM EDT

EXELON CORP

$EXC4CIK: 0001109357

Subscribe to track EXC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Exelon Corp ($EXC) | Bowers William P (Director) acquired 1,067 deferred phantom share equivalents at $40.40/share ($43,107 total value) on 2026-09-30 via a deferred compensation plan.

Comprehensive Analysis

Transaction Overview

On September 30, 2026, William P. Bowers, a member of the Board of Directors of Exelon Corp ($EXC), acquired 1,067 deferred phantom share equivalents at an implied price of $40.40 per share, totaling approximately $43,107.

Filing Details

  • Plan / Structure: The phantom share equivalents are held in the reporting person's Exelon stock fund account under a multi-fund, non-qualified deferred compensation plan for directors.
  • Settlement: These phantom units are payable in cash on a 1-for-1 basis following the conclusion of Bowers' board service.
  • Post-Transaction Holdings: Following this acquisition, Bowers holds 22,546 deferred phantom share equivalents, which also reflects 212 units accrued via automatic dividend reinvestment.

Market & Governance Impact

This filing represents a routine director compensation award under an established deferred compensation program. Because it reflects scheduled equity-based compensation rather than an open-market discretionary purchase or sale, it carries low trading significance for market participants.

Topics:#Exelon#EXC#InsiderTrading#DeferredComp#CorporateGovernance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.